Company page
Sprint Bioscience Ab
Sprint Bioscience AB is a public company listed on the Swedish market under the ticker SPRINT. The company has a market capitalization of approximately 48.17 million SEK. Sprint Bioscience focuses on developing innovative therapies for cancer treatment.
- Ticker
- SPRINT:OMXSTO
- Asset type
- Stock
- Market cap
- $48.2M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- OMXSTO
- Currency
- SEK